Comparison of second-line chemotherapy regimens in advanced biliary tract cancer: a systematic review, meta-analysis, and population-based cohort study
FOLFIRINOX demonstrates numerically favorable outcomes compared to current second-line regimens for advanced BTC, with manageable toxicities. These findings suggest FOLFIRINOX as a potential second-line option, warranting further prospective validation and patient selection refinement.
Authors
- Galam Leem (ORCID: https://orcid.org/0000-0001-6490-0911)
- Moon Jae Chung (ORCID: https://orcid.org/0000-0002-5920-8549)
- Seungmin Bang (ORCID: https://orcid.org/0000-0001-5209-8351)
- Yun Hak Kim (ORCID: https://orcid.org/0000-0002-9796-8266)
- Jeong Youp Park (ORCID: https://orcid.org/0000-0003-0110-8606)
- Hee Seung Lee (ORCID: https://orcid.org/0000-0002-2825-3160)
- Seung Woo Park (ORCID: https://orcid.org/0000-0002-2941-515X)
- Jeehoon Kim (ORCID: https://orcid.org/0000-0002-7533-6305)
- Ki‐Hun Kim (ORCID: https://orcid.org/0000-0002-4800-7573)
Institutions
- Yonsei University (KR)
- Severance Hospital (KR)
- Pusan National University Yangsan Hospital (KR)
- Pusan National University (KR)
Publication Details
- Journal
- International Journal of Surgery
- Published
- 2025-09-05
- DOI
- https://doi.org/10.1097/js9.0000000000003367
- Citations
- 1
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.01